Please ensure Javascript is enabled for purposes of website accessibility

How Risky Are Your Stocks?

By Dan Caplinger – Updated Apr 5, 2017 at 8:03PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

To know what the future may bring, you can't just look at past returns.

To know whether you've made a good investment, you need to know more than just the return you're expecting to make. You also have to understand exactly how much risk you're taking on -- and what your prospective losses could be if things go wrong.

Measuring risk, however, is a bit harder than measuring performance. While performance looks solely at what actually happened to your portfolio, risk measurements also try to incorporate what could have happened -- even if everything turned out fine in the end. Therefore, the math behind risk calculations is a little more complicated than figuring your total return.

So how do you know how risky your portfolio is? The key is to look at how your portfolio value changes over time.

Avoiding volatility
The underlying assumption behind risk-adjusted returns is that most investors prefer smooth, steady price appreciation over bumpy up-and-down stock moves. This basic axiom of modern portfolio theory explains why so many investors choose stocks: Even though stocks rise and fall constantly and are therefore relatively risky, they offer higher returns on average than less volatile investments such as cash and short-term bonds.

One place to start is by looking at the standard deviation of your portfolio's returns. If you invest in mutual funds, you don't have to do any calculations: Morningstar provides a standard deviation figure based on monthly returns over the past three years. For a portfolio of individual stocks, on the other hand, you'll have to go back over your brokerage statements and enter returns individually on a spreadsheet.

Either way, looking at standard deviations of different investments gives you an approximation of how risky they are compared to each other. Yet by itself, that figure isn't very useful -- you may be perfectly comfortable taking on additional risk as long as your returns adequately compensate you for it. To incorporate returns into the equation, you can go one step further and look at a special value called the Sharpe ratio.

Sharpen your pencils
The Sharpe ratio starts by looking at what low-risk investments such as Treasury bills pay. Because their returns aren't very volatile, these low-risk investments serve as a baseline for comparing riskier assets, such as stocks. By measuring how much extra return you earn in volatile investments, you can see whether you're getting the most return for the risk you're assuming.

For instance, if Treasury bills pay 2% and your fund earns an average of 6% with a standard deviation of 8%, then your Sharpe ratio is:

(6%-2%) / 8% = 0.5.

You can then compare your Sharpe ratio to a common benchmark, such as an S&P 500 index fund, to see whether the risk you're taking on makes sense. The larger the Sharpe ratio is, the better the risk-to-reward trade-off.

Different types of assets
To see how this works in action, it's useful to look at some common investments to see how they score. Here are a few asset classes:

Asset Class

3-Year Return

Standard Deviation

Sharpe Ratio

Large-Cap Growth

4.37%

10.6

(0.02)

Large-Cap Value

2.92%

10.6

(0.12)

Small-Cap Growth

6.67%

14.7

0.08

Small-Cap Value

4.24%

13.3

(0.16)

International

7.42%

12.4

0.53

Source: Morningstar.

As you can see, large-cap stocks -- whether they be growth companies such as Apple (NASDAQ:AAPL) and Gilead Sciences (NASDAQ:GILD) or value stocks such as ExxonMobil (NYSE:XOM) or Pfizer (NYSE:PFE) -- have roughly the same standard deviation, and so their Sharpe ratios differ only as a result of growth's outperformance in recent years.

Meanwhile, a portfolio of small-caps such as Olin (NYSE:OLN) and Energy Conversion Devices (NASDAQ:ENER) has greater risk as measured by standard deviation. But because small-cap growth stocks have performed so much better than the overall market, the return more than justifies the extra risk. Similarly, investing in a portfolio of international stocks such as Novartis (NYSE:NVS) creates a huge Sharpe score.

Be careful
The main problem with these methods is that they're backward-looking. Just as there's no guarantee that the best-performing stocks will keep doing well, you can't expect that low-risk stocks will always carry little risk. These methods also make some statistical assumptions about returns that are more simplistic than experience shows.

So whether you invest in mutual funds or individual stocks, you should take exact calculations of risk with a grain of salt. The general idea, though, is sound: Taking huge amounts of risk to eke out a little extra return can come back to bite you in the long run, so it's important to have at least some idea of how risky your portfolio really is.

For more on managing risk, read about:

Apple is a recommendation of Motley Fool Stock Advisor. Find out what Fool co-founders Tom and David Gardner believe will help you get through the bear market with flying colors. Full access is yours with a free 30-day trial.

Fool contributor Dan Caplinger hasn't given up on individual stocks, but he has plenty of his money in mutual funds. He doesn't own shares of the companies mentioned in this article. Pfizer is a Motley Fool Income Investor selection and a Motley Fool Inside Value pick. Try any of our Foolish newsletter services free for 30 days. The Fool's disclosure policy involves no risk at all.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Apple Inc. Stock Quote
Apple Inc.
AAPL
$150.43 (-1.51%) $-2.31
Exxon Mobil Corporation Stock Quote
Exxon Mobil Corporation
XOM
$85.75 (-5.32%) $-4.82
Pfizer Inc. Stock Quote
Pfizer Inc.
PFE
$44.08 (-1.10%) $0.49
Novartis AG Stock Quote
Novartis AG
NVS
$76.01 (-1.47%) $-1.13
Gilead Sciences, Inc. Stock Quote
Gilead Sciences, Inc.
GILD
$62.86 (-1.43%) $0.91
Olin Corporation Stock Quote
Olin Corporation
OLN
$44.09 (-2.54%) $-1.15

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.